{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:52:13Z","timestamp":1789581133902,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,16]]},"DOI":"10.1093\/infdis\/jiy684","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T15:11:15Z","timestamp":1543331475000},"page":"1389-1397","source":"Crossref","is-referenced-by-count":23,"title":["Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics\u2014Sexually Transmitted Disease Surveillance Network, United States, 2010\u20132016"],"prefix":"10.1093","volume":"219","author":[{"given":"Laura M","family":"Mann","sequence":"first","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Llata","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine W","family":"Flagg","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Hong","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore","family":"Asbel","sequence":"additional","affiliation":[{"name":"City of Philadelphia Department of Public Health, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli","family":"Carlos-Henderson","sequence":"additional","affiliation":[{"name":"County of Los Angeles Department of Public Health, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne P","family":"Kerani","sequence":"additional","affiliation":[{"name":"Seattle and King County Public Health, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kohn","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Pathela","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Baltimore City Health Department, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Torrone","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"2019041610125706500_CIT0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2019041610125706500_CIT0002","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"2019041610125706500_CIT0003","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"2019041610125706500_CIT0004","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"2019041610125706500_CIT0005","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/infdis\/jir652","article-title":"Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study","volume":"204","author":"Anic","year":"2011","journal-title":"J Infect Dis"},{"key":"2019041610125706500_CIT0006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","author":"Insinga","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041610125706500_CIT0007","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1073\/pnas.80.2.560","article-title":"Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers","volume":"80","author":"Gissmann","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019041610125706500_CIT0008","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US Assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2019041610125706500_CIT0009","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2019041610125706500_CIT0010","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunization practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0011","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0012","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007\u20132013, and postlicensure vaccine safety monitoring, 2006\u20132014 \u2013 United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0013","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0014","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.15585\/mmwr.mm6633a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years \u2014 United States, 2016","volume":"66","author":"Walker","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0016","first-page":"1117","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041610125706500_CIT0017","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1097\/QAI.0000000000001413","article-title":"Increasing human papillomavirus vaccine coverage among men who have sex with men\u2014National HIV Behavioral Surveillance, United States, 2014","volume":"75","author":"Oliver","year":"2017","journal-title":"J Acq Immun Def Synd"},{"key":"2019041610125706500_CIT0018","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.vaccine.2010.10.018","article-title":"Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries","volume":"29","author":"Wong","year":"2011","journal-title":"Vaccine"},{"key":"2019041610125706500_CIT0019","first-page":"463","article-title":"The biology of genital human papillomaviruses.","volume-title":"Sexually transmitted diseases","author":"Egelkrout","year":"2008","edition":"4"},{"key":"2019041610125706500_CIT0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/OLQ.0000000000000077","article-title":"Prevalence of genital warts among sexually transmitted disease clinic patients\u2014Sexually Transmitted Disease Surveillance Network, United States, January 2010 to December 2011","volume":"41","author":"Llata","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2019041610125706500_CIT0021","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"key":"2019041610125706500_CIT0022","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006\u20132014","volume":"108","author":"Flagg","year":"2018","journal-title":"Am J Public Health"},{"key":"2019041610125706500_CIT0023","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007\u20132010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"2019041610125706500_CIT0024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2019041610125706500_CIT0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2019041610125706500_CIT0026","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"2019041610125706500_CIT0027","author":"Centers for Disease Control and Prevention"},{"key":"2019041610125706500_CIT0028","author":"National Cancer Institute"},{"key":"2019041610125706500_CIT0029","article-title":"Flagg EW, Torrone EA. Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006\u20132014. Am J Public Health. 2018; 108:112\u20139."},{"key":"2019041610125706500_CIT0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0b013e318247925e","article-title":"A comparison of sexual behavior patterns among men who have sex with men and heterosexual men and women","volume":"60","author":"Glick","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019041610125706500_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"key":"2019041610125706500_CIT0032","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/OLQ.0b013e3182315584","article-title":"HPV vaccine implementation in STD clinics\u2013STD Surveillance Network","volume":"39","author":"Meites","year":"2012","journal-title":"Sex Transm Dis"},{"key":"2019041610125706500_CIT0033","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007435-199711000-00009","article-title":"Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity","volume":"24","author":"Celum","year":"1997","journal-title":"Sex Transm Dis"},{"key":"2019041610125706500_CIT0034","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"2019041610125706500_CIT0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/9\/1389\/28460022\/jiy684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:10:04Z","timestamp":1555420204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/9\/1389\/5219029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,11,29]]},"published-print":{"date-parts":[[2019,4,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy684","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5,1]]},"published":{"date-parts":[[2018,11,29]]}}}